Korro Bio, Inc. (KRRO) — Financial Flexibility Index
Korro Bio, Inc. (KRRO) has a Financial Flexibility Index of -0.25x as of March 2026. Free cash flow of $-16.05 Million (operating CF $-16.07 Million minus capex $21.00K) represents 0% of total liabilities ($63.99 Million). Check KRRO cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Korro Bio, Inc. Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Korro Bio, Inc. across 9 annual periods. For the full cash flow conversion analysis, see how efficiently does Korro Bio, Inc. generate cash.
Annual Financial Flexibility Index for Korro Bio, Inc. (2017–2025)
Year-by-year free cash flow to debt coverage for Korro Bio, Inc.. Explore KRRO operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.26x | $-78.04 Million | $-78.56 Million | $62.07 Million | ▼ -96.3% |
| 2024 | -0.64x | $-42.17 Million | $-60.07 Million | $65.83 Million | ▲ +44.2% |
| 2023 | -1.15x | $-59.45 Million | $-67.28 Million | $51.75 Million | ▼ -309.8% |
| 2022 | -0.28x | $-48.43 Million | $-53.65 Million | $172.77 Million | ▲ +44.7% |
| 2021 | -0.51x | $-27.65 Million | $-32.09 Million | $54.53 Million | ▲ +4.9% |
| 2020 | -0.53x | $-38.52 Million | $-45.19 Million | $72.23 Million | ▼ -184.4% |
| 2019 | 0.63x | $35.28 Million | $34.22 Million | $55.86 Million | ▲ +439.1% |
| 2018 | -0.19x | $-16.59 Million | $-17.02 Million | $89.06 Million | ▲ +27.8% |
| 2017 | -0.26x | $-12.75 Million | $-14.61 Million | $49.43 Million | — |